https://vettapharma.com/pharmaceutical-news/lilly-omvoh-il-23p19-data-shows-durable-remission-in-inflammatory-bowel-disease-patients/ 2026-05-06T07:20:38Z VETTAPHARMA en Lilly Omvoh IL-23p19 data shows durable remission in inflammatory bowel disease patients 2026-05-06T07:20:34Z Blog https://vettapharma.com/pharmaceutical-news/lupin-receives-fda-approval-for-glycerol-phenylbutyrate-liquid/ 2026-05-06T07:13:27Z VETTAPHARMA en Lupin Receives FDA Approval for Glycerol Phenylbutyrate Liquid 2026-05-06T07:13:22Z Blog https://vettapharma.com/pharmaceutical-news/sanofi-enters-new-growth-era-as-belen-garijo-takes-charge-globally/ 2026-05-05T10:22:21Z VETTAPHARMA en Sanofi enters new growth era as Belén Garijo takes charge globally 2026-05-05T10:22:17Z Blog https://vettapharma.com/pharmaceutical-news/amgens-300m-investment-boosts-u-s-manufacturing-capacity/ 2026-05-05T07:57:44Z VETTAPHARMA en Amgen's $300M Investment Boosts U.S. Manufacturing Capacity 2026-05-05T07:57:39Z Blog